Daily News | A complete guide to Spotlight PA’s investigations of Pennsylvania’s flawed medical marijuana program
from Spotlight PA this year has uncovered serious flaws in Pennsylvania’s medical marijuana program and prompted calls for change from doctors, patients, industry leaders, and policymakers.
Medical experts shared the investigation online and stressed the importance of patients using federally approved medication, such as buprenorphine and methadone, for addiction treatment. The Department of Health has declined to say whether it’s made any changes to its oversight of online marketing by dispensaries. The department has repeatedly said it doesn’t have authority over medical marijuana card companies, and lawmakers haven’t introduced any recent bills to expand the agency’s power over those companies.
“Is it fair? Probably not,” James said. “Does it serve its purpose for everybody involved? No. I understand why it’s in place. Maybe it’s time for a new opportunity to look at how it’s impacting everybody in general.” Employers and workers alike have asked for greater clarity, but the legislature and governor have so far failed to explicitly outline the rights of scores of employers and workers, Spotlight PA reported earlier this month.There are multiple bills in the legislature that would impact the rights of workers. It’s too soon to know whether any will gain significant traction before the session ends in November.